Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and Improve Frailty Outcomes
Recruiting now · Not applicable
Conditions studied: Sarcopenia, Acute Lymphoblastic Leukemia
In brief
This is a small trial testing out a new approach before doing a bigger study. Researchers are observing a group of children/adolescents (ages 5-17) with acute lymphoblastic leukemia (ALL) and testing a physical activity and exercise program on a group of them who after 5 weeks of treatment show signs of weakness or frailty. Kids who are NOT losing muscle aren't part of the exercise trial - they're just monitored over time to see how they do. The goal: To see if an exercise program helps kids who are getting weaker from acute lymphoblastic leukemia treatment build back/maintain their strength, compared to kids who don't do the extra intervention. The study will also look at if this way of measuring muscle weakness works well for kids with cancer.
Key facts
- Study ID
- NCT07325305
- Run by
- Murdoch Childrens Research Institute
- People needed
- 60
- Starts
- 2026-02-24
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2026-07-06
Who can join
Age: 5 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 5-17 years at the time of consent
- New diagnosis of acute lymphoblastic leukaemia ≤7 days
- Is planned to receive management for their cancer treatment at the trial site for the duration of the trial period
- Has a legally acceptable representative capable of understanding the informed consent document in English and providing consent on the participant's behalf
- Have a family electronic device that can be linked with the tool to be used (Fitbit)
You may not qualify if…
- none
Where it is running
- Royal Children's Hospital — Melbourne, Victoria, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.